Myocardial Fibrosis as an Early Manifestation of Hypertrophic CardiomyopathyCarolyn Y. Ho, Christine E. Seidman, Begoña López et al.|New England Journal of Medicine|2010Cited by 706
Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected MyocarditisChristoph Gräni, Raymond Y. Kwong, Loïc Bière et al.|Journal of the American College of Cardiology|2017Cited by 426
Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic CardiomyopathySara Saberi, Daniel Jacoby, Nuno Cardim et al.|Circulation|2020Cited by 234
Comparative Definitions for Moderate-Severe Ischemia in Stress Nuclear, Echocardiography, and Magnetic Resonance ImagingLeslee J. Shaw, Pamela S. Douglas, Daniel S. Berman et al.|JACC. Cardiovascular imaging|2014Cited by 204
Diltiazem Treatment for Pre-Clinical Hypertrophic Cardiomyopathy Sarcomere Mutation CarriersCarolyn Y. Ho, Christine E. Seidman, Neal K. Lakdawala et al.|JACC Heart Failure|2014Cited by 158